241 related articles for article (PubMed ID: 16338832)
1. Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome.
Khatib R; Johnson LB; Fakih MG; Riederer K; Khosrovaneh A; Shamse Tabriz M; Sharma M; Saeed S
Scand J Infect Dis; 2006; 38(1):7-14. PubMed ID: 16338832
[TBL] [Abstract][Full Text] [Related]
2. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection.
Khatib R; Riederer K; Saeed S; Johnson LB; Fakih MG; Sharma M; Tabriz MS; Khosrovaneh A
Clin Infect Dis; 2005 Sep; 41(5):594-8. PubMed ID: 16080079
[TBL] [Abstract][Full Text] [Related]
3. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
5. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
Chang FY; Peacock JE; Musher DM; Triplett P; MacDonald BB; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):333-9. PubMed ID: 14530782
[TBL] [Abstract][Full Text] [Related]
7. Favorable prognosis of Staphylococcus aureus bacteremia originating from soft tissues: a prospective study of fifty cases.
Khosrovaneh A; Sharma M; Khatib R
Scand J Infect Dis; 2005; 37(1):6-10. PubMed ID: 15764183
[TBL] [Abstract][Full Text] [Related]
8. Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology.
Schreiber MP; Chan CM; Shorr AF
J Crit Care; 2011 Aug; 26(4):395-401. PubMed ID: 21036521
[TBL] [Abstract][Full Text] [Related]
9. [Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].
Falcone M; Carfagna P; Cassone M; Pistella E; Pavoni G; Nofroni I; Serra P; Venditti M
Ann Ital Med Int; 2002; 17(3):166-72. PubMed ID: 12402664
[TBL] [Abstract][Full Text] [Related]
10. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
[TBL] [Abstract][Full Text] [Related]
11. A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance.
Berger J; Diab-Elschahawi M; Blacky A; Pernicka E; Spertini V; Assadian O; Koller W; Aichberger KJ
Am J Infect Control; 2010 Dec; 38(10):839-45. PubMed ID: 20650546
[TBL] [Abstract][Full Text] [Related]
12. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
Melzer M; Eykyn SJ; Gransden WR; Chinn S
Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
[TBL] [Abstract][Full Text] [Related]
13. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
Ahmad NM; Rojtman AD
Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
[TBL] [Abstract][Full Text] [Related]
15. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
[TBL] [Abstract][Full Text] [Related]
16. [Bacteremia by Staphylococcus aureus: analysis of 311 episodes].
Rubio M; Romero J; Corral O; Roca V; Picazo JJ
Enferm Infecc Microbiol Clin; 1999 Feb; 17(2):56-64. PubMed ID: 10193063
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
Kopp BJ; Nix DE; Armstrong EP
Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia.
Lesse AJ; Mylotte JM
Am J Infect Control; 2006 Dec; 34(10):642-50. PubMed ID: 17161739
[TBL] [Abstract][Full Text] [Related]
19. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
Lewis T; Chaudhry R; Nightingale P; Lambert P; Das I
Int J Infect Dis; 2011 Feb; 15(2):e131-5. PubMed ID: 21134776
[TBL] [Abstract][Full Text] [Related]
20. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.
Goldberg E; Paul M; Talker O; Samra Z; Raskin M; Hazzan R; Leibovici L; Bishara J
J Antimicrob Chemother; 2010 Aug; 65(8):1779-83. PubMed ID: 20507860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
